• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

Introduction to 2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid (CAS No. 2171731-99-8) in Modern Chemical Biology

2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid, identified by the CAS number 2171731-99-8, is a sophisticated organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, featuring a unique spirocyclic structure and an amide-like functional group, exhibits promising properties that make it a valuable candidate for various biochemical applications. The compound’s structural design incorporates a spiro[3.3]heptan-2-yl moiety, which contributes to its distinct stereochemistry and reactivity, while the tert-butoxycarbonyl (Boc) group enhances its stability and versatility in synthetic chemistry.

The Boc-protected amino acid derivative nature of this compound underscores its utility in peptide synthesis and drug development. In recent years, advancements in medicinal chemistry have highlighted the importance of such protected amino acids in designing novel therapeutic agents. The spirocyclic framework, particularly the spiro[3.3]heptane core, has been explored for its potential to modulate biological pathways by influencing enzyme activity and receptor binding. This structural motif is not only intriguing from a synthetic perspective but also offers unique physicochemical properties that can be exploited in drug design.

Recent studies have demonstrated that derivatives of spirocyclic compounds exhibit enhanced binding affinity and selectivity towards target proteins, making them attractive for developing small-molecule inhibitors. The presence of the Boc-amino group in 2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid allows for controlled deprotection under mild acidic conditions, facilitating its integration into larger molecular architectures during peptide coupling reactions. This feature is particularly valuable in the synthesis of complex peptidomimetics, which are increasingly recognized for their role in modulating biological processes.

The spiro[3.3]heptan-2-yl acetic acid component of the molecule introduces a rigid bicyclic system that can influence the conformational preferences of peptides and proteins. Such structural constraints are often employed to optimize pharmacokinetic properties, including solubility, metabolic stability, and tissue distribution. Moreover, the acetic acid moiety provides a carboxylate functionality that can participate in hydrogen bonding interactions with biological targets, further enhancing binding affinity.

In the context of contemporary drug discovery, 2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid represents a compelling example of how structural innovation can lead to novel therapeutic opportunities. Researchers are increasingly leveraging such compounds to explore new mechanisms of action for diseases ranging from cancer to neurodegenerative disorders. The spirocyclic scaffold has been associated with molecules that exhibit potent activity against kinases and other enzymes involved in disease pathways, suggesting that this compound may serve as a precursor for next-generation therapeutics.

The Boc-protection strategy employed in this compound’s synthesis is also noteworthy from an industrial perspective. Boc protection is widely used in peptide chemistry due to its robustness under various reaction conditions and ease of removal without affecting sensitive functional groups. This makes 2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid a versatile building block for medicinal chemists seeking to develop novel peptides or peptidomimetics with improved pharmacological profiles.

Recent computational studies have begun to unravel the structural dynamics of spirocyclic compounds like this one, providing insights into how their unique conformations influence biological interactions. These studies often employ molecular modeling techniques to predict binding affinities and identify key interaction points with target proteins. Such computational approaches are increasingly integrated into drug discovery pipelines, allowing researchers to rapidly screen large libraries of compounds for potential therapeutic activity.

The broader significance of spirocyclic compounds in chemical biology cannot be overstated. These molecules have been implicated in various biological processes due to their ability to mimic natural products and interact with biological macromolecules in unique ways. The specific combination of structural features found in 2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid, including the spiro[3.3]heptane core and Boc-amino group, positions it as a promising candidate for further exploration in both academic research and industrial applications.

In conclusion, 2-{[(tert-butoxy)carbonyl]amino}-2-{spiro[3.3]heptan-2-yl}acetic acid (CAS No. 2171731-99-8) represents an innovative compound with significant potential in chemical biology and pharmaceutical research. Its unique structural features, including the spirocyclic framework and Boc-protection strategy, make it a valuable tool for designing novel therapeutic agents. As research continues to uncover new applications for such compounds, their role in addressing complex diseases will likely expand, solidifying their importance in modern drug discovery efforts.

• 155905-77-4(Boc-L-cyclobutylglycine)
• 2089648-39-3(2-{(tert-butoxy)carbonylamino}-2-(3,3-dimethylcyclobutyl)acetic acid)
• 2231665-90-8((2R)-2-{bicyclo[1.1.1]pentan-1-yl}-2-{[(tert-butoxy)carbonyl]amino}acetic acid)
• 2231672-90-3(2-(tert-butoxycarbonylamino)-2-cuban-1-yl-acetic acid)
• 951789-86-9((S)-2-((tert-butoxycarbonyl)amino)-2-(1-methylcyclohexyl)acetic acid)
• 2322750-43-4(Bicyclo[1.1.1]pentane-1-propanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-, (αR)-)
• 1807854-18-7(2-{bicyclo[1.1.1]pentan-1-yl}-2-{[(tert-butoxy)carbonyl]amino}acetic acid)
• 155905-78-5((R)-tert-Butoxycarbonylamino-cyclobutyl-aceticacid)
• 361441-97-6((2S)-2-(adamantan-1-yl)-2-{[(tert-butoxy)carbonyl]amino}acetic acid)
• 1844853-98-0((2R)-2-(tert-butoxycarbonylamino)-2-cuban-1-yl-acetic acid)